Series C funding round for NiKang Therapeutics raising $200M in May 2021
Series C funding round for NiKang Therapeutics raising $200M in May 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$250M
Top Valuation
-
NiKang Therapeutics raised $200M in a Series C round.
The round was announced on 05/01/21.